Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
AstraZeneca
Boehringer Ingelheim
Incyte Corporation
Astellas Pharma Inc
Travera Inc
Iambic Therapeutics, Inc
Nammi Therapeutics Inc
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Jazz Pharmaceuticals
Novartis
Bayer
Fate Therapeutics
Actuate Therapeutics Inc.
Conjupro Biotherapeutics, Inc.
858 Therapeutics, Inc.
EMD Serono
GlaxoSmithKline
SystImmune Inc.
Terremoto Biosciences Inc.
Orano Med LLC
Seagen Inc.
Filamon LTD
Varian, a Siemens Healthineers Company
Novartis
PMV Pharmaceuticals, Inc
Pfizer
AstraZeneca
Hoffmann-La Roche
BeOne Medicines
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
ViroMissile, Inc.
Replimune Inc.
Yuhan Corporation
Carevive Systems, Inc.
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
MBrace Therapeutics
Angiex, Inc.
New Phase Ltd.
Poseida Therapeutics, Inc.
IDEAYA Biosciences
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.